Click on the red icons on the map to learn about each registered team. This page is constantly updated to to catalog the latest teams that have joined the competition.
Kinemed Emeryville, CA, USA KineMed is a company focused on translational medicine, the development and implementation of predictive strategies to optimize decision-making at the interface of basic pharmaceutical research and human clinical applications.
Saneron CCEL Therapeutics Tampa, FL, USA Saneron is a biotechnology R&D company, focused on neurological and cardiac cell therapy for the early intervention and treatment of several devastating or deadly diseases, which lack adequate treatment options.
Chemigen Indianapolis, IN, USA Chemigen is a biotechnology start-up company that is developing therapeutic agents which block progression of neurodegenerative diseases.
Guo-fu Hu Boston, MA, USA Dr. Hu's research has been mainly focused on angiogenesis. He has been studying the function and mechanism of angiogenin (ANG), a 14kDa angiogenic ribonuclease, in cancer progression, and more recently, on neurodegeneration.
Oleg Butovsky, Howard Weiner Boston, MA, USA The Weiner lab is focused on questions related to neuroimmunoloy and the interface of the immune system with the nervous system, both in health and disease. Dr. Butovsky and Dr. Weiner are actively studying immune mechanisms and novel treatment approaches to multiple sclerosis, Alzheimer's disease and amyotrophic lateral sclerosis.
Jay Chung Bethesda, MD, USA ALS is characterized by increased oxidative stress in motor neurons. Oxidative damages include DNA damage, which can lead to cell death. Dr. Chung is interested in the DNA damage signaling pathways (e.g. Chk2, ATM, ATR and DNA-PK) as targets for ALS therapy.
Victorio Rodriguez/Cerebril Parma, OH, USA Dr. Rodriguez is interested in therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress,which includes chronic neurodegenerative disorders including aAzheimer's dementia, ALS, and others.
